Provided by Tiger Trade Technology Pte. Ltd.

WisdomTree BioRevolution Fund

23.39
+1.125.05%
Volume:2K
Turnover:44.15K
Market Cap:4.68M
PE:- -
High:23.40
Open:23.08
Low:23.01
Close:22.27
52wk High:24.20
52wk Low:14.71
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.37
T/O Rate:0.95%
Dividend:0.77
Dividend Rate:3.30%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Dow Jones
·
Sep 12

Sector Update: Healthcare Stocks Ease in Afternoon Trading

MT Newswires Live
·
Sep 12

Moderna Inc Stock (MRNA) Moved Up by 8.63% on Sep 11: A Full Analysis

TradingKey
·
Sep 12

Moderately bullish activity in Moderna with shares up 8.03%

TIPRANKS
·
Sep 12

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 12

Eli Lilly Stock (LLY) in Focus as Company Completes $3.8 Billion AtaiBeckley Purchase

TIPRANKS
·
Sep 11

Eli Lilly Completes Acquisition of AtaiBeckley

Reuters
·
Sep 11

Lilly Completes Acquisition of Ataibeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions

THOMSON REUTERS
·
Sep 11

Berenberg Boosts Price Target on Moderna to $100 From $45, Keeps Hold Rating

MT Newswires Live
·
Sep 11

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)

TIPRANKS
·
Sep 11

MS Cuts Novo Nordisk on Growth Prospects, Patent Expiry Risks

Reuters
·
Sep 11

Growth Without AI: 8 Stock Picks

Dow Jones
·
Sep 11

Insight Guru Flags Valuation Flip as Merck Trades at 52.2x Operating Profit vs Lilly 25.3x

Reuters
·
Sep 11

Eli Lilly is Maintained at Reduce by HSBC

Dow Jones
·
Sep 10

Eli Lilly’s GLP-1 Windfall to Fund Push into Women’s Health - Bloomberg News

Reuters
·
Sep 10

HSBC Adjusts Price Target on Eli Lilly and Co. to $940 From $850, Keeps Reduce Rating

MT Newswires Live
·
Sep 10

Twist Bioscience Price Target Announced at $45.00/Share by BWS Financial

Dow Jones
·
Sep 10

Moderna Set for 3 Near-Term INT Data Readouts, UBS Says

MT Newswires Live
·
Sep 09

Twist Bioscience initiated with a Sell at BWS Financial

TIPRANKS
·
Sep 09

UBS Initiates Coverage on Twist Bioscience With Neutral Rating, $144 Price Target

MT Newswires Live
·
Sep 09